Publicacions en què col·labora amb ALFREDO BLANCO QUIROS (68)

2012

  1. Ascorbate-dependent decrease of the mucosal immune inflammatory response to gliadin in coeliac disease patients

    Allergologia et Immunopathologia, Vol. 40, Núm. 1, pp. 3-8

2011

  1. Sublingual immunotherapy is safe in children, but the challenge is how to increase its efficiency?

    Allergologia et Immunopathologia

2009

  1. Early infections and later allergic diseases

    Allergologia et Immunopathologia

  2. From autoimmune enteropathy to the IPEX (immune dysfunction, polyendocrinopathy, enteropathy, X-linked) syndrome

    Allergologia et Immunopathologia

  3. Is it true that coeliacs do not digest gliadin? Degradation pattern of gliadin in coeliac disease small intestinal mucosa

    Gut

2008

  1. ALOX5 promoter genotype and response to montelukast in moderate persistent asthma

    Respiratory Medicine, Vol. 102, Núm. 6, pp. 857-861

  2. Cytokine, chemokine and immune activation pathway profiles in celiac disease: An immune system activity screening by expression macroarrays

    Drug Target Insights, Vol. 2008, Núm. 3

  3. Higher constitutive IL15Rα expression and lower IL-15 response threshold in coeliac disease patients

    Clinical and Experimental Immunology, Vol. 154, Núm. 1, pp. 64-73

  4. Similar cytokine profiles in response to infection with respiratory syncytial virus type a and type B in the upper respiratory tract in infants

    Intervirology, Vol. 51, Núm. 2, pp. 112-115

2007

  1. Persistence of proinflammatory response after severe respiratory syncytial virus disease in children

    Journal of Allergy and Clinical Immunology

  2. Predominance of Th2 cytokines, CXC chemokines and innate immunity mediators at the mucosal level during severe respiratory syncytial virus infection in children

    European Cytokine Network, Vol. 18, Núm. 3, pp. 162-167

2006

  1. Common variable immunodeficiency. Old questions are getting clearer

    Allergologia et Immunopathologia, Vol. 34, Núm. 6, pp. 263-275

  2. Farmacogenética en el tratamiento del asma

    Anales de Pediatria

  3. Farmacogenética en el tratamiento del asma

    Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP ), Vol. 64, Núm. 3, pp. 221

  4. Interleukin (IL)-1β, IL-6 and IL-8 in nasal secretions: A common role for innate immunity in viral bronchial infection in infants?

    British Journal of Biomedical Science, Vol. 63, Núm. 4, pp. 173-175

  5. Interleukin 18 maintains a long-standing inflammation in coeliac disease patients

    Clinical and Experimental Immunology, Vol. 146, Núm. 3, pp. 479-485

  6. Tachyphylaxis to β2-agonists in Spanish asthmatic patients could be modulated by β2-adrenoceptor gene polymorphisms

    Respiratory Medicine, Vol. 100, Núm. 6, pp. 1072-1078

2005

  1. Antibody levels to Bordetella pertussis in 10-yr-old children with atopy and atopic asthma

    Pediatric Allergy and Immunology, Vol. 16, Núm. 8, pp. 637-640

  2. IL6, IL10 and TGFB1 gene polymorphisms in coeliac disease: Differences between DQ2 positive and negative patients

    Allergologia et Immunopathologia, Vol. 33, Núm. 5, pp. 245-249

  3. Interleukin-13 is involved in the survival of children with sepsis

    Acta Paediatrica, International Journal of Paediatrics, Vol. 94, Núm. 12, pp. 1828-1831